Arvee Laboratories (India) Limited (ARVEE) - Net Assets

Latest as of September 2025: Rs314.41 Million INR ≈ $3.40 Million USD

Based on the latest financial reports, Arvee Laboratories (India) Limited (ARVEE) has net assets worth Rs314.41 Million INR (≈ $3.40 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs405.81 Million ≈ $4.39 Million USD) and total liabilities (Rs91.40 Million ≈ $988.48K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Arvee Laboratories (India) Limited strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs314.41 Million
% of Total Assets	77.48%
Annual Growth Rate	62.38%
5-Year Change	45.82%
10-Year Change	1083.74%
Growth Volatility	874.57

Arvee Laboratories (India) Limited - Net Assets Trend (2013–2025)

This chart illustrates how Arvee Laboratories (India) Limited's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Arvee Laboratories (India) Limited stock valuation.

Annual Net Assets for Arvee Laboratories (India) Limited (2013–2025)

The table below shows the annual net assets of Arvee Laboratories (India) Limited from 2013 to 2025. Also explore how fast is Arvee Laboratories (India) Limited growing its equity to track the company's year-over-year net asset growth rate.

Year	Net Assets	Change
2025-03-31	Rs312.61 Million ≈ $3.38 Million	+7.38%
2024-03-31	Rs291.14 Million ≈ $3.15 Million	+3.75%
2023-03-31	Rs280.62 Million ≈ $3.03 Million	+17.21%
2022-03-31	Rs239.42 Million ≈ $2.59 Million	+11.68%
2021-03-31	Rs214.38 Million ≈ $2.32 Million	+14.71%
2020-03-31	Rs186.89 Million ≈ $2.02 Million	+13.53%
2019-03-31	Rs164.62 Million ≈ $1.78 Million	+15.94%
2018-03-31	Rs141.99 Million ≈ $1.54 Million	+238.56%
2017-03-31	Rs41.94 Million ≈ $453.55K	+58.81%
2016-03-31	Rs26.41 Million ≈ $285.60K	+86.66%
2015-03-31	Rs14.15 Million ≈ $153.01K	-53.79%
2014-03-31	Rs30.62 Million ≈ $331.12K	+3192.26%
2013-03-31	Rs930.00K ≈ $10.06K	--

Equity Component Analysis

This analysis shows how different components contribute to Arvee Laboratories (India) Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 42470.5% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2025)

Component	Amount	Percentage
Retained Earnings	Rs183.05 Million	58.56%
Common Stock	Rs110.20 Million	35.25%
Other Components	Rs19.36 Million	6.19%
Total Equity	Rs312.61 Million	100.00%

Arvee Laboratories (India) Limited Competitors by Market Cap

The table below lists competitors of Arvee Laboratories (India) Limited ranked by their market capitalization.

Company	Market Cap
Dorsavi Ltd AU:DVL	$20.75 Million
BCWORLD PHARM. Co. Ltd KQ:200780	$20.75 Million
Fredonia Mining Inc V:FRED	$20.75 Million
NHN Bugs Corp KQ:104200	$20.75 Million
Oxford Nanopore Technologies Ltd LSE:ONT	$20.74 Million
S-Fuelcell co. Ltd KQ:288620	$20.74 Million
Biofish Holding AS OL:BFISH	$20.74 Million
Only World Group Holdings Bhd KLSE:5260	$20.74 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Arvee Laboratories (India) Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 291,140,220 to 312,613,000, a change of 21,472,780 (7.4%).
Net income of 21,474,000 contributed positively to equity growth.
Other comprehensive income decreased equity by 180,940,000.
Other factors increased equity by 180,938,780.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Rs21.47 Million	+6.87%
Other Comprehensive Income	Rs-180.94 Million	-57.88%
Other Changes	Rs180.94 Million	+57.88%
Total Change	Rs-	7.38%

Book Value vs Market Value Analysis

This analysis compares Arvee Laboratories (India) Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 6.16x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 2062.52x to 6.16x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2013-03-31	Rs0.08	Rs174.06	x
2014-03-31	Rs2.78	Rs174.06	x
2015-03-31	Rs1.28	Rs174.06	x
2016-03-31	Rs2.40	Rs174.06	x
2017-03-31	Rs3.81	Rs174.06	x
2018-03-31	Rs16.85	Rs174.06	x
2019-03-31	Rs14.94	Rs174.06	x
2020-03-31	Rs16.96	Rs174.06	x
2021-03-31	Rs19.45	Rs174.06	x
2022-03-31	Rs21.73	Rs174.06	x
2023-03-31	Rs25.46	Rs174.06	x
2024-03-31	Rs26.42	Rs174.06	x
2025-03-31	Rs28.27	Rs174.06	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Arvee Laboratories (India) Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 6.87%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 5.58%
• Asset Turnover: 1.01x
• Equity Multiplier: 1.22x
Recent ROE (6.87%) is above the historical average (4.36%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2013	46.24%	1.25%	0.39x	95.78x	Rs337.00K
2014	0.61%	0.16%	0.68x	5.69x	Rs-2.87 Million
2015	-116.41%	-12.70%	0.50x	18.40x	Rs-17.88 Million
2016	7.10%	0.70%	0.76x	13.33x	Rs-766.90K
2017	37.00%	4.51%	0.96x	8.51x	Rs11.32 Million
2018	7.67%	2.43%	1.01x	3.11x	Rs-3.31 Million
2019	13.75%	4.19%	1.45x	2.26x	Rs6.17 Million
2020	12.30%	5.13%	1.33x	1.80x	Rs4.30 Million
2021	12.49%	5.68%	1.15x	1.91x	Rs5.34 Million
2022	10.75%	6.38%	1.04x	1.62x	Rs1.80 Million
2023	14.68%	6.72%	1.58x	1.38x	Rs13.13 Million
2024	3.61%	3.47%	0.79x	1.31x	Rs-18.60 Million
2025	6.87%	5.58%	1.01x	1.22x	Rs-9.79 Million

Industry Comparison

This section compares Arvee Laboratories (India) Limited's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

Industry: Specialty Chemicals
Average net assets among peers: $8,529,824,500
Average return on equity (ROE) among peers: 8.70%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Arvee Laboratories (India) Limited (ARVEE)	Rs314.41 Million	46.24%	0.29x	$20.74 Million
Aarti Industries Limited (AARTIIND)	$11.89 Billion	21.60%	1.49x	$1.93 Billion
Aarti Surfactants Limited (AARTISURF)	$1.36 Billion	-4.77%	1.06x	$49.06 Million
ABM International Limited (ABMINTLLTD)	$176.83 Million	-10.10%	0.47x	$5.19 Million
Advanced Enzyme Technologies Limited (ADVENZYMES)	$11.40 Billion	10.49%	0.11x	$348.52 Million
Aether Industries Limited (AETHER)	$24.56 Billion	8.94%	0.30x	$2.34 Billion
Akzo Nobel India Limited (AKZOINDIA)	$7.29 Billion	29.38%	1.77x	$1.60 Billion
Alkali Metals Limited (ALKALI)	$445.25 Million	-13.03%	1.09x	$9.65 Million
Alkyl Amines Chemicals Limited (ALKYLAMINE)	$9.90 Billion	22.72%	0.39x	$1.03 Billion
Ami Organics Limited (AMIORG)	$13.20 Billion	12.02%	0.17x	$1.18 Billion
Anupam Rasayan India Limited (ANURAS)	$5.07 Billion	9.71%	1.61x	$1.49 Billion

About Arvee Laboratories (India) Limited

NSE:ARVEE India Specialty Chemicals

Market Cap

$20.74 Million

Rs1.92 Billion INR

Market Cap Rank

#25086 Global

#1385 in India

Share Price

Rs174.06

Change (1 day)

+1.15%

52-Week Range

Rs133.86 - Rs290.78

All Time High

Rs306.70